Strain Information | |
---|---|
Image | |
BRC No. | RBRC05473 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129S6-Mad2l2<tm1Myo> |
Former Common name | Rev7 KO, B6-Mad2l2 KO |
H-2 Haplotype | |
ES Cell line | CSL3[129S6/SvEvTac] |
Background strain | |
Appearance | |
Strain development | Developed by Yoshiki Murakumo, Nagoya University Graduate School of Medicine in 2009. The mutant mice were backcrossed to C57BL/6. |
Strain description | Rev7 (Mad2l2) knockout mice. Homozygous mutant mice lack germ cells due to apoptosis of primordial germ cell in the middle phase of the embryonic development. |
Colony maintenance | Heterozygote x Wild-type [C57BL/6JJmsSlc] |
References | A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce C M, Fishel R J. Biol. Chem., 275, 4391-4397 (2000). 10660610The REV7 subunit of DNA polymerase zeta is essential for primordial germ cell maintenance in the mouse. Watanabe N, Mii S, Asai N, Asai M, Niimi K, Ushida K, Kato T, Enomoto A, Ishii H, Takahashi M, Murakumo Y J. Biol. Chem., 288(15):10459-10471 (2013). 23463509 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Mad2l2 MGI:1919140 | MAD2 mitotic arrest deficient-like 2 | 4 | Mad2l2<tm1Ymu> MGI:5505390 | targeted mutation 1, Yoshiki Murakumo | |||
neo | neomycin resistance gene (E. coli) | 4 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 18 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Mouse phosphoglycerate kinase promoter, E. coli Neomycin resistance gene, SV40 PolyA signal, Mouse Rev7 gene |
Research application | |
Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Biol. Chem., 288(15):10459-10471 (2013). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. For profit use of the BIOLOGICAL RESSOURCE, the RECIPIENT must contact with the Intellectual Property Office, Nagoya University to obtain a prior written consent. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Yoshiki Murakumo (Nagoya University) |
Strain Status | ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |